Habib Joseph Dable's most recent trade in SpyGlass Pharma Inc. was a trade of 27,400 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SpyGlass Pharma Inc | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 27,400 | 27,400 | - | - | Stock Option (right to buy) | |
| Day One Biopharma Inc | Habib Joseph Dable | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Nov 2025 | 66,660 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2025 | 66,660 | 66,660 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2025 | 32,335 | 32,335 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Habib Joseph Dable | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Nov 2025 | 32,335 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Relay Therapeutics Inc | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2025 | 207,931 | 207,931 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 128.12 per share. | 18 Jun 2025 | 3,902 | 12,644 (0%) | 0% | 128.1 | 499,924 | Common Stock |
| PepGen Inc | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Day One Biopharma Inc | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 22,500 | 22,500 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 15,000 | 15,000 | - | - | Restricted Stock Unit (RSU) | |
| PepGen Inc | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 4,570 | 4,570 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 2,242 | 8,742 (0%) | 0% | 0 | Common Stock | |
| Jade Biosciences Inc | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Day One Biopharma Inc | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 32,335 | 32,335 | - | - | Stock Option (right to buy Common Stock) | |
| Jade Biosciences Inc | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 1,531 | 1,531 | - | - | Stock Option (Right to Buy) |